Veradigm Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDRX research report →
About the company
Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations.
- CEO
- Donald D. Trigg
- IPO
- 1999
- Employees
- 2,450
- HQ
- Chicago, IL, US
Price Chart
- Market Cap
- $865.28M
- P/E
- -7.60
- P/S
- 1.47
- P/B
- 0.65
- EV/EBITDA
- 10.92
- Div Yield
- 0.00%
- Gross Margin
- 52.45%
- Op Margin
- -4.61%
- Net Margin
- -14.70%
- ROE
- -7.13%
- ROIC
- -0.66%
- Revenue
- $588.02M · 1.83%
- Net Income
- $-86,462,000 · -164.31%
- EPS
- $-0.67 · -165.05%
- Op Income
- $-27,103,000
- FCF YoY
- 206.10%
- 52W High
- $6.00
- 52W Low
- $3.00
- 50D MA
- $4.78
- 200D MA
- $4.67
- Beta
- 0.54
- Avg Volume
- 266.10K
Get TickerSpark's AI analysis on MDRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Sacks Jonathan S | other | 42,507 |
| Jun 1, 26 | STONEHILL CAPITAL MANAGEMENT LLC | other | 42,507 |
| May 27, 26 | Greyenbuhl Christian | other | 0 |
| May 10, 26 | Jacobson Eric L | other | 1,584 |
| May 1, 26 | Jacobson Eric L | other | 75,000 |
| Apr 1, 26 | Syed Tehsin M | other | 220,986 |
| Apr 1, 26 | Baker Tally | other | 110,493 |
| Apr 1, 26 | Trigg Donald | other | 552,465 |
| Nov 3, 25 | Baker Tally | other | 105,999 |
| Nov 3, 25 | Syed Tehsin M | other | 423,998 |
Our MDRX coverage
Recent articles, reports, and earnings notes.
No research on MDRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDRX report →Similar companies
Peers in the same neighborhood.